Siplizumab (Anti-CD2)

Ask supplier a question | View on supplier's website

Siplizumab (Anti-CD2) is a humanized IgG1 monoclonal antibody targeting CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2562
Sku #	A2562-1mg
Pricing	1mg, $270.00

Feedback